InspireMD Inc

NEW
STU:II2 (USA)  
€ 0.60 +0.030 (+5.26%) Jun 26
At Loss
P/B:
0.76
Market Cap:
€ 29.32M ($ 33.94M)
Enterprise V:
€ -4.53M ($ -5.25M)
Volume:
0
Avg Vol (2M):
2.80K
Trade In:

Business Description

InspireMD Inc
NAICS : 339112 SIC : 3841
ISIN : US45779A8466

Total Employee Number:

127
Description
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Name Current Vs Industry Vs History
Cash-To-Debt
13.37
Equity-to-Asset
0.77
Debt-to-Equity
0.07
Debt-to-EBITDA
-0.06
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-8.24
Distress
Grey
Safe
Beneish M-Score
-3.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
41.27
9-Day RSI
35.16
14-Day RSI
32.75
3-1 Month Momentum %
-44.48
6-1 Month Momentum %
-54.52
12-1 Month Momentum %
-57.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
5.15
Quick Ratio
4.82
Cash Ratio
4.4
Days Inventory
148.87
Days Sales Outstanding
65.15
Days Payable
76.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-73.5
Shareholder Yield %
-119.19
Name Current Vs Industry Vs History
Gross Margin %
28.06
Operating Margin %
-480.57
Net Margin %
-472.98
EBITDA Margin %
-475.71
FCF Margin %
-370.39
OCF Margin %
-356.58
ROE %
-121.29
ROA %
-92.83
ROIC %
-418.19
3-Year ROIIC %
-371.18
ROC (Joel Greenblatt) %
-867.8
ROCE %
-113.85
Moat Score
2
Tariff Resilience Score
5

InspireMD Inc Filings

Filing Date Document Date Form
No Filing Data

InspireMD Inc Stock Events

Financials Calendars
Event Date Price (€)
Third quarter earnings conference call for 2026 2026-11-04 08:30 In 130 days
Third quarter earnings results for 2026 2026-11-04 In 129 days
Second quarter earnings conference call for 2026 2026-08-05 08:30 In 39 days
Second quarter earnings results for 2026 2026-08-05 In 38 days
General meeting for 2026 2026-06-03 10:00 0.86 (+2.99%)
Guidance call for 2026 2026-05-13 16:20 1.01 (-3.81%)
First quarter earnings conference call for 2026 2026-05-04 16:30 0.98 (+0.00%)
First quarter earnings results for 2026 2026-05-04 0.98 (+0.00%)
25th Annual Needham Virtual Healthcare Conference 2026-04-14 12:45 1.13 (+4.63%)
Fourth quarter earnings conference call for 2025 2026-03-18 08:30 1.48 (+6.47%)
Show
Entries

Articles on InspireMD Inc

No articles.